Correlative biomarkers to optimize breast cancer treatment and prevention strategiesVSVered StearnsASAshley SchreierSSSarah SchmitzLELauren Elreda+2 moreBreast Cancer Research Foundation · 2024–2026BCRF-24-154Ending soon
Targeting Adipose Inflammation: A Rational Approach to Preventing Breast CancerXKXi Kathy ZhouBreast Cancer Research Foundation · 2018–2019BCRF-18-034
Adolescent and early adulthood dietary patterns and effects on breast cancer intermediate endpoints/risk factorsRTRulla TamimiBreast Cancer Research Foundation · 2020–2020 · via Fred Hutchinson Cancer Research CenterFHCRC 203865-01
Isolation and Characterization of Metastatic Breast Cancer Cell-of-OriginTITan InceBreast Cancer Research Foundation · 2020–2021BCRF 204266-01
New Approaches to Breast Cancer PreventionVSVered StearnsBreast Cancer Research Foundation · 2023–2024BCRF-23-154
Identifying Synthetically Lethal Compounds for Breast Cancer TherapyWKWilliam K. HollomanBreast Cancer Research Foundation · 2017–2018BCRF-17-068
Identifying Synthetically Lethal Compounds For Therapy Of Homologous Recombination Deficient (HRD) Breast CancersWKWilliam K. HollomanBreast Cancer Research Foundation · 2020–2021BCRF-20-068
Optimization of Immune Checkpoint Inhibition During Radiation-Induced Vaccination in Breast CancerSCSilvia Chiara FormentiGGGiorgio Ga. InghiramiSDSandra DemariaBreast Cancer Research Foundation · 2018–2019BCRF 17-053
Optimization of immune checkpoint inhibition during radiation-induced vaccination in breast cancerSCSilvia Chiara FormentiSDSandra DemariaXKXi Kathy ZhouBreast Cancer Research Foundation · 2022–2023BCRF-22-053
Optimization of immune checkpoint inhibition during radiation-induced vaccination in breast cancerSCSilvia Chiara FormentiSDSandra DemariaXKXi Kathy ZhouBreast Cancer Research Foundation · 2023–2024BCRF-23-053
Optimization of immune checkpoint inhibition during radiation-induced vaccination in breast cancerSCSilvia Chiara FormentiLYLiron YoffeSDSandra DemariaWHWen H. ShenBreast Cancer Research Foundation · 2024–2026BCRF-24-053Ending soon
DNA Vaccines Against Cancer and Infectious OrganismsJDJedd D WolchokTMTaha MerghoubAAAnais AssouvieBreast Cancer Research Foundation · 2024–2026BCRF-24-176Ending soon
Identification of Drugs that Inhibit RAD52 and TLS PolymerasesWKWilliam K. HollomanBreast Cancer Research Foundation · 2014–2015BCRF 170207-01
Identifying synthetically lethal compounds for breast cancer therapyWKWilliam K. HollomanBreast Cancer Research Foundation · 2018–2019BCRF 190494-01
Identifying synthetically lethal compounds for therapy of homologous recombination deficient (HRD) breast cancersWKWilliam K. HollomanBreast Cancer Research Foundation · 2021–2022BCRF-21-068
Targeting BRCA1-mutant breast cancer cells with folate and vitamin CJBJohn BlenisGBGuillermo Burgos BarraganBreast Cancer Research Foundation · 2024–2026 · via Dana-Farber Cancer InstituteBCRF -24-022Ending soon
DNA Vaccines Against Cancer and Infectious OrganismsJDJedd D WolchokTMTaha MerghoubBreast Cancer Research Foundation · 2022–2023BCRF-22-176
Establishment of a network of African American breast surgeons supporting a breast cancer biobankLALisa Ann NewmanBreast Cancer Research Foundation · 2022–2023BCRF-22-194
Breast Cancer Drivers in Black Women: Society to CellsLALisa Ann NewmanBreast Cancer Research Foundation · 2025–2026HEI-25-010Ending soon
International Center for the Study of Breast Cancer Subtypes: A Unique Biobank and Research/Training ProgramLALisa Ann NewmanBreast Cancer Research Foundation · 2026–2027BCRF-26-194Ending soon